These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice. Hull RL; Watts MR; Kodama K; Shen ZP; Utzschneider KM; Carr DB; Vidal J; Kahn SE Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E703-9. PubMed ID: 15899941 [TBL] [Abstract][Full Text] [Related]
24. The role of mitochondrial apoptotic pathway in islet amyloid-induced β-cell death. Wong HY; Hui Q; Hao Z; Warnock GL; Woo M; Luciani DS; Marzban L Mol Cell Endocrinol; 2021 Nov; 537():111424. PubMed ID: 34400259 [TBL] [Abstract][Full Text] [Related]
25. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets. Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885 [TBL] [Abstract][Full Text] [Related]
26. Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes. Wijesekara N; Ahrens R; Wu L; Ha K; Liu Y; Wheeler MB; Fraser PE Diabetes Obes Metab; 2015 Oct; 17(10):1003-6. PubMed ID: 26095311 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro. Hogan MF; Meier DT; Zraika S; Templin AT; Mellati M; Hull RL; Leissring MA; Kahn SE Endocrinology; 2016 Sep; 157(9):3462-8. PubMed ID: 27404391 [TBL] [Abstract][Full Text] [Related]
29. Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Wang F; Hull RL; Vidal J; Cnop M; Kahn SE Diabetes; 2001 Nov; 50(11):2514-20. PubMed ID: 11679429 [TBL] [Abstract][Full Text] [Related]
31. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646 [TBL] [Abstract][Full Text] [Related]
32. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice. Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789 [TBL] [Abstract][Full Text] [Related]
33. Cotransplantation of Polymerized Hemoglobin Reduces β-Cell Hypoxia and Improves β-Cell Function in Intramuscular Islet Grafts. Espes D; Lau J; Quach M; Banerjee U; Palmer AF; Carlsson PO Transplantation; 2015 Oct; 99(10):2077-82. PubMed ID: 26426924 [TBL] [Abstract][Full Text] [Related]
34. Islet amyloid polypeptide promotes beta-cell proliferation in neonatal rat pancreatic islets. Karlsson E; Sandler S Diabetologia; 2001 Aug; 44(8):1015-8. PubMed ID: 11484079 [TBL] [Abstract][Full Text] [Related]
35. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice. Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506 [TBL] [Abstract][Full Text] [Related]
36. Human IAPP amyloidogenic properties and pancreatic β-cell death. Fernández MS Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501 [TBL] [Abstract][Full Text] [Related]
37. XIAP inhibition of β-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model. Plesner A; Soukhatcheva G; Korneluk RG; Verchere CB Islets; 2010; 2(1):18-23. PubMed ID: 21099289 [TBL] [Abstract][Full Text] [Related]
38. Cu(II) inhibits hIAPP fibrillation and promotes hIAPP-induced beta cell apoptosis through induction of ROS-mediated mitochondrial dysfunction. Ma L; Li X; Wang Y; Zheng W; Chen T J Inorg Biochem; 2014 Nov; 140():143-52. PubMed ID: 25108186 [TBL] [Abstract][Full Text] [Related]
39. Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: An effect attenuated by phycocyanin. Li XL; Chen T; Wong YS; Xu G; Fan RR; Zhao HL; Chan JC Int J Biochem Cell Biol; 2011 Apr; 43(4):525-34. PubMed ID: 21163363 [TBL] [Abstract][Full Text] [Related]
40. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway. Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]